Schülke Mayr AGBusiness Directories,Company Directories

Company Name: Corporate Name:	Schülke & Mayr AG
Company Title:
Company Description:
Keywords to Search:
Company Address:	Ob. Zäune 12,8001 Zürich,,Switzerland
ZIP Code: Postal Code:
Telephone Number:
Fax Number:
Website:
Email:
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
STF Schweizerische Textilfachschule
St. Annahof
Schule für Musiktheorie

Next company profile:
Schulthess Druck AG
Schwander Philipp AG
Schweizerisch-Liechtensteinischer Gebäudetechnikverband (suissetec)

Company News:

Warning Letters | FDA
Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed
Untitled Letters | FDA
These letters are supplied by the CDER Freedom of Information Office and only cover Office of Prescription Drug Promotion's untitled letters
Warning Letters and Notice of Violation Letters to . . .
Visit the FOI page for instructions on how to submit an FOI request or for more information on the status of an issue in a particular warning letter or notice of violation
Swedish drugmaker Rechon gets hit with FDA warning letter for . . .
Rechon Life Sciences, a Sweden-based CDMO, was hit with a warning letter from the FDA following an inspection that uncovered unsanitary conditions at its aseptic production plant
Regulatory Procedures Manual - U. S. Food and Drug Administration
Importers FDA may issue Warning Letters and Untitled Letters to importers, owners, or consignees of FDA-regulated imports when they engage in practices that violate the Act
FDA Warning Letter to Swedish Company - from Microbiology to . . .
During a CGMP inspection at Rechon Life Sciences in Sweden, the FDA identified a number of significant violations, as a result of which the manufactured medicinal products are considered ‘adulterated’ within the meaning of the Federal Food, Drug, and Cosmetic Act (FD C Act)
FDA Warning Letters – Association of Food and Drug Officials
Explore FDA’s comprehensive resources to understand different warning letter types, learn from real examples, and discover best practices for responding to FDA concerns